BEHAVIOURAL SCIENCE IN CANCER SCREENING, CONTROL AND COMMUNICATION
With
Dr Rachael Dodd
Senior Research Fellow,
The Daffodil Centre, a Cancer Council NSW & The University of Sydney Joint Venture
Sydney, Australia
RESEARCHER PROFILE
Filmed in Sydney | April 2025
Dr Dodd completed her undergraduate in Psychology (2007), Masters in Health Psychology (2009) and PhD in Psychology (2016) in the UK. Her PhD focused on the psychosocial impact of HPV in people diagnosed with head and neck cancer, which resulted in the development of an education resource which is being implemented into clinical practice here in Australia and is available online. Dr Dodd relocated to The University of Sydney in Australia in 2017, following the completion of her PhD. Her research capitalised on her expertise in HPV and focused on the changes to the cervical screening program that commenced in Australia in 2017.
Dr Dodd has an established international reputation as a behavioural scientist in cancer control and communication. Since completing her PhD in 2016, Dr Dodd has been awarded a three-year University of Sydney Postdoctoral Research Fellowship (2018-2021) and a three-year Research Fellowship at The Daffodil Centre (current). Dr Dodd is the co-chair of the ‘Strengthening and optimising approaches to cancer prevention, screening, and early detection’ hub at The Daffodil Centre (with more than 130 staff and students).
Dr Dodd has published 78 research papers and is a CI on grants worth over $20 million. This has included being the lead investigator of an International Lung Cancer Foundation Young Investigator Grant, to co-design decision support tools for lung cancer screening in Australia and she is leading a consortium to develop the suite of information materials and education resources for the upcoming National Lung Cancer Screening Program.
Source: Supplied
https://orcid.org/0000-0002-8080-6359
-
New treatments for patients with mental illness
Associate Professor Bernadette Fitzgibbon is a neuroscientist with several decades of experience in researching, developing, and translating novel therapies for mental health and chronic pain conditions. This includes the application and optimisation of brain stimulation and psychedelic therapies, overseeing large multi-site intervention trials, both within Australia and abroad. Through her work, she has developed meaningful collaborations with consumers, volunteers, policy makers, and services providers, ensuring that the outcomes of her work contribute towards real-world clinical impact.
-
Development of novel analytical and diagnostic tools using nanotechnology and microfluidics
Dr Alain Wuethrich is an NHMRC Emerging Leader fellow and ARC DECRA awardee at the Australian Institute for Bioengineering and Nanotechnology.
Hailing from Switzerland, research focuses on the development of novel analytical and diagnostic tools that harness nanotechnology and microfluidics; two rapidly growing fields with high potential to provide diagnostic solutions needed for precision medicine.
-
Inner ear organoids for the study of human hearing and balance
Dr Jackie Ogier is an auditory neuroscientist, with a research focus on the molecular biology of hair cells, the specialised sensory receptors in the ear that detect sound and balance. She is a postdoctoral research fellow in the laboratory of A/Prof Bryony Nayagam, supported by a prestigious Passe and Williams foundation fellowship.
Dr Ogier’s experience broadly spans the genetics of hearing loss, disease modelling, micro dissection, primary cell culture, stem cell culture, organoids, and proteomics. Overall, she aims to generate knowledge of hearing and vestibular sensory biology.
